Impairment of the extrusion transporter for asymmetric dimethyl-l-arginine: A novel mechanism underlying vasospastic angina

Biochemical and Biophysical Research Communications

Volumn 423, Issue 2, 2012, Pages 218-223

  Closs, Ellen I ^a   Ostad, Mir A ^a   Simon, Alexandra ^a   Warnholtz, Ascan ^a   Jabs, Alexander ^a   Habermeier, Alice ^a   Daiber, Andreas ^a   Förstermann, Ulrich ^a   Münzel, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

ADMA; CAT (cationic amino acid transporter); Endothelial dysfunction; ENOS uncoupling; L arginine; Superoxide; System y +; System y +L; Y +LAT

Indexed keywords

ACETYLSALICYLIC ACID; AMINO ACID TRANSPORTER; AMLODIPINE; ANTIDEPRESSANT AGENT; ARGININE; CLOPIDOGREL; CORONARY VASODILATING AGENT; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; N(G) NITROARGININE METHYL ESTER; N(G),N(G) DIMETHYLARGININE; ORNITHINE; PHORBOL DIBUTYRATE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ADULT; ANGINA PECTORIS; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CASE REPORT; CONTROLLED STUDY; EFFUSION; ENDOTHELIAL DYSFUNCTION; HUMAN; HUMAN CELL; INTRACELLULAR MEMBRANE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SPASTICITY; THROMBOCYTE AGGREGATION;

ADULT; ANGINA PECTORIS; ARGININE; BLOOD PLATELETS; CORONARY VASOSPASM; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; SUPEROXIDES;

ANGINA;

EID: 84862902598     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.044     Document Type: Article

References (18)

1. Prinzmetal M., Ekmekci A., Kennamer R., Kwoczynski J.K., Shubin H., Toyoshima H. Variantform of angina pectoris, previously undelineated syndrome. JAMA 1960, 174:1794-1800.
2. Kawano H., Ogawa H. Endothelial function and coronary spastic angina. Intern. Med. 2005, 44:91-99.
3. Kaski J.C., Crea F., Meran D., Rodriguez L., Araujo L., Chierchia S., Davies G., Maseri A. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 1986, 74:1255-1265.
4. Kaski J.C., Maseri A., Vejar M., Crea F., Hackett D. Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. J. Am. Coll. Cardiol. 1989, 14:1456-1463.
5. Kugiyama K., Ohgushi M., Motoyama T., Sugiyama S., Ogawa H., Yoshimura M., Inobe Y., Hirashima O., Kawano H., Soejima H., Yasue H. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J. Am. Coll. Cardiol. 1997, 30:920-926.
6. Motoyama T., Kawano H., Kugiyama K., Hirashima O., Ohgushi M., Tsunoda R., Moriyama Y., Miyao Y., Yoshimura M., Ogawa H., Yasue H. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J. Am. Coll. Cardiol. 1998, 32:1672-1679.
7. Kugiyama K., Yasue H., Okumura K., Ogawa H., Fujimoto K., Nakao K., Yoshimura M., Motoyama T., Inobe Y., Kawano H. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996, 94:266-271.
8. Motoyama T., Kawano H., Kugiyama K., Okumura K., Ohgushi M., Yoshimura M., Hirashima O., Yasue H. Flow-mediated, endothelium-dependent dilatation of the brachial arteries is impaired in patients with coronary spastic angina. Am. Heart J. 1997, 133:263-267.
9. Hori T., Matsubara T., Ishibashi T., Ozaki K., Tsuchida K., Mezaki T., Tanaka T., Nasuno A., Kubota K., Nakamura Y., Yamazoe M., Aizawa Y., Nishio M. Significance of asymmetric dimethylarginine (ADMA) concentrations during coronary circulation in patients with vasospastic angina. Circ. J. 2003, 67:305-311.
10. Vallance P., Leiper J. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1023-1030.
11. Verrey F., Closs E.I., Wagner C.A., Palacin M., Endou H., Kanai Y. CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch. 2004, 447:532-542.
12. Pollock J.S., Forstermann U., Mitchell J.A., Warner T.D., Schmidt H.H., Nakane M., Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 1991, 88:10480-10484.
13. Wu G., Haynes T.E., Li H., Yan W., Meininger C.J. Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis. Biochem. J. 2001, 353:245-252.
14. Simon A., Plies L., Habermeier A., Martine U., Reining M., Closs E.I. Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells. Circ. Res. 2003, 93:813-820.
15. Camacho J.A., Obie C., Biery B., Goodman B.K., Hu C.A., Almashanu S., Steel G., Casey R., Lambert M., Mitchell G.A., Valle D. Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter. Nat. Genet. 2001, 22:151-158.
16. Scaglia F., Brunetti-Pierri N., Kleppe S., Marini J., Carter S., Garlick P., Jahoor F., O'Brien W., Lee B. Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism. J. Nutr. 2004, 134:2775-2782. discussion 2796S-2797S.
17. Kamada Y., Nagaretani H., Tamura S., Ohama T., Maruyama T., Hiraoka H., Yamashita S., Yamada A., Kiso S., Inui Y., Ito N., Kayanoki Y., Kawata S., Matsuzawa Y. Vascular endothelial dysfunction resulting from l-arginine deficiency in a patient with lysinuric protein intolerance. J. Clin. Invest. 2001, 108:717-724.
18. Kayanoki Y., Kawata S., Yamasaki E., Kiso S., Inoue S., Tamura S., Taniguchi N., Matsuzawa Y. Reduced nitric oxide production by l-arginine deficiency in lysinuric protein intolerance exacerbates intravascular coagulation. Metabolism 1999, 48:1136-1140.